Understanding complex disease biology:
How genetics is transforming modern medical practice

Drug discovery remains a high-cost, high-risk and attritional activity. To remove the uncertainty in R&D and develop effective drug treatments for patients, we must first understand the underlying mechanisms that cause diseases better.

Too often, a lack of diverse patient data and the complexity of polygenic and heterogenous diseases results in promising programs failing due to an inability to demonstrate clinical efficacy.

In this webinar, PrecisionLife and Sano Genetics discuss groundbreaking research approaches that have overcome these challenges to uncover the genetics of long COVID and enable the discovery and development of new and better treatment options for patients with complex chronic diseases.

 

Thumbnail Image

Thank you, click to play

Unlock webinar: Enter your details

 

Our panel of experts

 

Group 48095544

Charlotte Guzzo

COO & Co-Founder
Sano Genetics

Linkedin
noun-globe-5360693-F75338
Group 48095547 (1)

Steve Gardner

CEO
PrecisionLife

Linkedin
noun-globe-5360693-F75338
Group 48095542 (1)

Heath O'Brien

Senior Bioinformatician
Sano Genetics

Linkedin
noun-globe-5360693-F75338